- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£386GBP
Mucodyne is a brand of respiratory drugs used to treat a variety of conditions, including bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). It is a combination of two active ingredients, guaifenesin and bromhexine hydrochloride, which work together to reduce mucus production and improve airway clearance. The drug is available in both oral and inhalation forms, and is often prescribed in combination with other medications.
Mucodyne is a popular choice for treating respiratory conditions due to its effectiveness and relatively low cost. It is widely available in pharmacies and online, and is often prescribed by doctors.
The Mucodyne market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, Merck, Pfizer, and Novartis. Other companies, such as Sun Pharmaceuticals and Cipla, also offer generic versions of the drug. Show Less Read more